Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel, safe, fast and efficient treatment for Her2‐positive and negative bladder cancer utilizing an EGF‐anthrax toxin chimera

4 Oct 2019

Abstract excerpt

Bladder cancer is the sixth most common cancer in the United States, and it exhibits an alarming 70% recurrence rate. Thus, the development of more efficient antibladder cancer approaches is a high priority. Accordingly, this work provides the basis for a transformative anticancer strategy that takes advantage of the unique characteristics of the bladder. Unlike mucin‐shielded normal bladder cells, cancer cells...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Hepatitis B Virus Studies
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31584195
DOI: 10.1002/ijc.32719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel, safe, fast and efficient treatment for Her2‐positive and negative bladder cancer utilizing an EGF‐anthrax toxin chimeraPMID 31584195Read ↗

Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells.Semantic proximity Read ↗

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF-α as Main Mechanism of ActionSemantic proximity Read ↗

Cytomembrane-targeted photodynamic priming triggers extracellular vesicle storm for deep penetration and complete destruction of bladder cancerSemantic proximity Read ↗

Anti-tumor effect of IL-2 and TRAIL expressed by recombinant Salmonella: an immunotherapeutic proposal against bladder cancer by iNOS, Caspases activation and modulation of the immune systemSemantic proximity Read ↗

Development of folate receptor targeting chimeras for cancer selective degradation of extracellular proteinsSemantic proximity Read ↗

Exploring the Potentials of Antibody–siRNA Conjugates in Tumor Cell Gene Silencing without Cationic AssistanceSemantic proximity Read ↗

A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency.Semantic proximity Read ↗

A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model.Semantic proximity Read ↗

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignanciesSemantic proximity Read ↗

Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery.Semantic proximity Read ↗

Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethality.Semantic proximity Read ↗

Halogenated Boroxine K2 (B3O3F4 Oh) Modulates Metabolic Phenotype and Autophagy in Human Bladder Carcinoma 5637 Cell LineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.